Document is current
Any future updates will be listed below
-
Authors
Wolfenson, Zoe https://orcid.org/0009-0008-2207-5755
Benavides, Daniel
Lewis, Connor J. https://orcid.org/0000-0002-8204-5848
Vezina, Gilbert https://orcid.org/0000-0002-1999-336X
Wolfe, Lynne https://orcid.org/0000-0001-7628-5741
Macnamara, Ellen https://orcid.org/0000-0002-9418-3287
Yang, John
Heiss, John D. https://orcid.org/0000-0002-3890-0165
Aldape, Kenneth https://orcid.org/0000-0001-5119-7550
Dampier, Chris https://orcid.org/0000-0003-3099-6462
Jackson, Sadhana https://orcid.org/0000-0001-6700-5621
Stone, Robert
Korones, David
Gahl, William A. https://orcid.org/0000-0002-2494-6752
Acosta, Maria T. https://orcid.org/0000-0001-8914-7401
-
Funding
Funding for this research was provided by:
National Institutes of Health
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 22 May 2025
First Online: 1 July 2025
Declarations
:
: This study was approved by the Institutional Review Board (IRB) of the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI). This study was carried out under NHGRI protocol 15-HG-0130. Clinical trial number: not applicable.
: The patient provided informed written assent for this manuscript to be published. The patient’s guardian also provided informed written consent for this manuscript to be published after reviewing the manuscript.
: The authors declare no competing interests.
